rs4627050
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs4627050(A;A) |
Make rs4627050(A;G) |
Make rs4627050(G;G) |
Reference | GRCh38 38.1/141 |
Chromosome | 11 |
Position | 18800490 |
is a | snp |
is | mentioned by |
dbSNP | rs4627050 |
dbSNP (classic) | rs4627050 |
ClinGen | rs4627050 |
ebi | rs4627050 |
HLI | rs4627050 |
Exac | rs4627050 |
Gnomad | rs4627050 |
Varsome | rs4627050 |
LitVar | rs4627050 |
Map | rs4627050 |
PheGenI | rs4627050 |
Biobank | rs4627050 |
1000 genomes | rs4627050 |
hgdp | rs4627050 |
ensembl | rs4627050 |
geneview | rs4627050 |
scholar | rs4627050 |
rs4627050 | |
pharmgkb | rs4627050 |
gwascentral | rs4627050 |
openSNP | rs4627050 |
23andMe | rs4627050 |
SNPshot | rs4627050 |
SNPdbe | rs4627050 |
MSV3d | rs4627050 |
GWAS Ctlg | rs4627050 |
GMAF | 0.3641 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23648065![]() |
Trait | Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin) |
Title | Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. |
Risk Allele | G |
P-val | 4E-6 |
Odds Ratio | 1.93 [1.452-2.572] |